BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 24952673)

  • 1. The inhibition of Rho kinase blocks cell migration and accumulation possibly by challenging inflammatory cytokines and chemokines on astrocytes.
    Guo MF; Meng J; Li YH; Yu JZ; Liu CY; Feng L; Yang WF; Li JL; Feng QJ; Xiao BG; Ma CG
    J Neurol Sci; 2014 Aug; 343(1-2):69-75. PubMed ID: 24952673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic potential of experimental autoimmune encephalomyelitis by Fasudil, a Rho kinase inhibitor.
    Yu JZ; Ding J; Ma CG; Sun CH; Sun YF; Lu CZ; Xiao BG
    J Neurosci Res; 2010 Jun; 88(8):1664-72. PubMed ID: 20077431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fasudil regulates T cell responses through polarization of BV-2 cells in mice experimental autoimmune encephalomyelitis.
    Chen C; Li YH; Zhang Q; Yu JZ; Zhao YF; Ma CG; Xiao BG
    Acta Pharmacol Sin; 2014 Nov; 35(11):1428-38. PubMed ID: 25263338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fasudil mediates cell therapy of EAE by immunomodulating encephalomyelitic T cells and macrophages.
    Liu CY; Guo SD; Yu JZ; Li YH; Zhang H; Feng L; Chai Z; Yuan HJ; Yang WF; Feng QJ; Xiao BG; Ma CG
    Eur J Immunol; 2015 Jan; 45(1):142-52. PubMed ID: 25287052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual roles of the adenosine A2a receptor in autoimmune neuroinflammation.
    Ingwersen J; Wingerath B; Graf J; Lepka K; Hofrichter M; Schröter F; Wedekind F; Bauer A; Schrader J; Hartung HP; Prozorovski T; Aktas O
    J Neuroinflammation; 2016 Feb; 13():48. PubMed ID: 26920550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nasal delivery of Fasudil-modified immune cells exhibits therapeutic potential in experimental autoimmune encephalomyelitis.
    Guo SD; Liu CY; Yu JW; Chai Z; Wang Q; Mi XT; Song GB; Li YH; Yang PW; Feng L; Xiao BG; Ma CG
    CNS Neurosci Ther; 2019 Jun; 25(6):783-795. PubMed ID: 30779332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective effect of a novel Rho kinase inhibitor WAR-5 in experimental autoimmune encephalomyelitis by modulating inflammatory response and neurotrophic factors.
    Li YH; Yu JZ; Xin YL; Feng L; Chai Z; Liu JC; Zhang HZ; Zhang GX; Xiao BG; Ma CG
    Exp Mol Pathol; 2015 Oct; 99(2):220-8. PubMed ID: 26112093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Astrocytes play a key role in EAE pathophysiology by orchestrating in the CNS the inflammatory response of resident and peripheral immune cells and by suppressing remyelination.
    Brambilla R; Morton PD; Ashbaugh JJ; Karmally S; Lambertsen KL; Bethea JR
    Glia; 2014 Mar; 62(3):452-67. PubMed ID: 24357067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting the shift from M1 to M2 macrophages in experimental autoimmune encephalomyelitis mice treated with fasudil.
    Liu C; Li Y; Yu J; Feng L; Hou S; Liu Y; Guo M; Xie Y; Meng J; Zhang H; Xiao B; Ma C
    PLoS One; 2013; 8(2):e54841. PubMed ID: 23418431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes of synapses in experimental autoimmune encephalomyelitis by using Fasudil.
    Yu JZ; Chen C; Zhang Q; Zhao YF; Feng L; Zhang HF; Meng J; Ma CG; Xiao BG
    Wound Repair Regen; 2016 Mar; 24(2):317-27. PubMed ID: 26789651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fasudil, a Rho kinase inhibitor, drives mobilization of adult neural stem cells after hypoxia/reoxygenation injury in mice.
    Ding J; Li QY; Yu JZ; Wang X; Sun CH; Lu CZ; Xiao BG
    Mol Cell Neurosci; 2010 Feb; 43(2):201-8. PubMed ID: 19913617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergistic and Superimposed Effect of Bone Marrow-Derived Mesenchymal Stem Cells Combined with Fasudil in Experimental Autoimmune Encephalomyelitis.
    Yu JW; Li YH; Song GB; Yu JZ; Liu CY; Liu JC; Zhang HF; Yang WF; Wang Q; Yan YP; Xiao BG; Ma CG
    J Mol Neurosci; 2016 Dec; 60(4):486-497. PubMed ID: 27573128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intranasal delivery of FSD-C10, a novel Rho kinase inhibitor, exhibits therapeutic potential in experimental autoimmune encephalomyelitis.
    Li YH; Yu JZ; Liu CY; Zhang H; Zhang HF; Yang WF; Li JL; Feng QJ; Feng L; Zhang GX; Xiao BG; Ma CG
    Immunology; 2014 Oct; 143(2):219-29. PubMed ID: 24749492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic administration of orexin A ameliorates established experimental autoimmune encephalomyelitis by diminishing neuroinflammation.
    Becquet L; Abad C; Leclercq M; Miel C; Jean L; Riou G; Couvineau A; Boyer O; Tan YV
    J Neuroinflammation; 2019 Mar; 16(1):64. PubMed ID: 30894198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gp130-dependent astrocytic survival is critical for the control of autoimmune central nervous system inflammation.
    Haroon F; Drögemüller K; Händel U; Brunn A; Reinhold D; Nishanth G; Mueller W; Trautwein C; Ernst M; Deckert M; Schlüter D
    J Immunol; 2011 Jun; 186(11):6521-31. PubMed ID: 21515788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Huperzine A inhibits CCL2 production in experimental autoimmune encephalomyelitis mice and in cultured astrocyte.
    Tian GX; Zhu XQ; Chen Y; Wu GC; Wang J
    Int J Immunopathol Pharmacol; 2013; 26(3):757-64. PubMed ID: 24067473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of NADPH oxidase activation reduces EAE-induced white matter damage in mice.
    Choi BY; Kim JH; Kho AR; Kim IY; Lee SH; Lee BE; Choi E; Sohn M; Stevenson M; Chung TN; Kauppinen TM; Suh SW
    J Neuroinflammation; 2015 May; 12():104. PubMed ID: 26017142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diminished cytokine and chemokine expression in the central nervous system of GMF-deficient mice with experimental autoimmune encephalomyelitis.
    Zaheer A; Sahu SK; Wu Y; Zaheer A; Haas J; Lee K; Yang B
    Brain Res; 2007 May; 1144():239-47. PubMed ID: 17316572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of Fasudil on miroglia and astrocytes in experimental autoimmune encephalomyelitis mice].
    Li YH; Liu CY; Zhang PJ; Yu JZ; Ji N; Yan YY; Feng L; Zhang HF; Xiao BG; Ma CG
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Dec; 28(12):1242-5. PubMed ID: 23232512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The therapeutic potential of Rho kinase inhibitor fasudil derivative FaD-1 in experimental autoimmune encephalomyelitis.
    Zhao YF; Zhang X; Ding ZB; Yang XW; Zhang H; Yu JZ; Li YH; Liu CY; Zhang Q; Zhang HZ; Ma CG; Xiao BG
    J Mol Neurosci; 2015 Mar; 55(3):725-32. PubMed ID: 25223373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.